Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amazônia Fitomedicamentos is a Brazilian biotechnology company dedicated to the research and development of innovative pharmaceuticals derived from Amazonian biodiversity. Founded by renowned researcher Luiz Francisco Pianowski, the company focuses on identifying and isolating bioactive compounds from native plants to treat complex diseases such as cancer and HIV. Its research portfolio includes the development of ingenol derivatives for reactivating latent HIV reservoirs and novel terpenes for anti-inflammatory and analgesic applications. The company is recognized for its role in bridging traditional botanical knowledge with rigorous clinical and pharmaceutical standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amazônia Fitomedicamentos.